Skip to main content
Fig. 2 | Cardio-Oncology

Fig. 2

From: The landscape of cardiovascular care in pediatric cancer patients and survivors: a survey by the ACC Pediatric Cardio-Oncology Work Group

Fig. 2

Medications prescribed for patients experiencing ventricular dysfunction before, during, or after cancer therapy, as reported by providers at pediatric centers (N = 65). ACE = angiotensin converting enzyme; MRB = mineralocorticoid receptor blocker. Unknown = provider answered they did not know

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us